Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10
Published January 17, 2018 · Recall initiated: December 5, 2017
Summary
FDA records drug Class III recall D-0153-2018, published January 17, 2018 and initiated December 5, 2017. Recalling firm: Sanofi-Aventis U.S. LLC; Status: Terminated; Reported quantity: 11,474 cartons of 10 syringes per carton; Lot: Lot #: 7S572, Exp. 04/2019. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL
What to do
Voluntary: Firm initiated · Letter
Get an email if ENOXAPARIN SODIUM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ENOXAPARIN SODIUM
- Manufacturer
- Sanofi-Aventis U.S. LLC
- Distributor
- Distributed nationwide.
- Lot
- Lot #: 7S572, Exp. 04/2019
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEnoxaparin Sodium Injection, USP, 30 mg/0.3 mL, packaged in 0.3 mL prefilled syringes further packaged in bagsSeptember 3, 2025
- FDAEnoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For SubcutaneousJanuary 3, 2024
- FDAGabapentin Tablets, USP, 800 mg, 500-count, Rx only, Made in India, PONDRUGS/16 134193, Distributed by: SolcoJanuary 17, 2018
- FDAEphedrine sulfate 5 mg/mL in 0.9% Sodium Chloride 10 mL in Single Dose Syringe, Total Volume 10 mL, Rx only,January 17, 2018
- FDAAccess 2 Immunoassay System, Catalog Number 81600N. In vitro diagnostic device used for the quantitative,January 10, 2018
- FDACADD-Legacy 1, Model 6400 Ambulatory Infusion Pump, REF 21-6400-51, PC 10008552-001, Smiths Medical ASD, Inc.January 10, 2018
Questions about this recall
Was Enoxaparin Sodium, Injection 120 mg/0.8 mL, pre-filled, packaged in 10-count cartons, Rx Only, Winthrop US., a business of Sanofi-aventis, U.S. LLC Bridgewater, NJ 08807, NDC 0955-1012-10 recalled?
Yes. FDA published recall D-0153-2018 on January 17, 2018. Reported hazard: Labeling: Label Error on Declared Strength. A single syringe labeled as 150 mg/1.0 mL was found packaged in a blister labeled as 120 mg/mL
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ENOXAPARIN SODIUM.